For the Cough+PVFM subjects, we found that PVFM and extrathoracic airway hyperresponsiveness responded positively to treatment and was significantly reduced for the Cough+PVFM group, [Figure 2a] and unchanged for the CC alone group, [Figure 2b]. This evidence concerns the gene CXCR1 and airway hyperresponsiveness.